-
-
-
-
-
-
-
PacBio reports fourth quarter revenue growth of 14% year-over-year
-
-
-
-
-
-
-
PacBio technology chosen for South Korea's national genome project
-
-
-
-
-
-
-
Pacific Bio (PACB) Board investigation sees allegations as unsubstantiated
-
-
-
-
-
-
-
Pacific Bio (PACB) Appoints Jim Gibson as CFO
-
-
-
-
-
-
-
Pacific Bio (PACB) Reports In-Line Q4 EPS, Misses on Revenue
-
-
-
-
-
-
-
Pacific Bio (PACB) Announces SPRQ Chemistry for Revio Sequencing Systems
-
-
-
-
-
-
-
Increasing unusual option volume: PACB ARKX VERU APP
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

